Margaritis Schinas and cabinet engagement with external stakeholders regarding pharmaceutical legislation

Kathrin Lauber a fait une demande de Accès à l'information à Secrétariat général de la Commission européenne

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

La demande est réussie.

Dear Secretariat General of the European Commission,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information related to Vice-President Margaritis Schinas (Promoting our European Way of Life) and his cabinet.

(1) Any minutes and agendas of meetings, between external stakeholders and VP Schinas and/or members of his cabinet, where the Pharmaceutical Strategy and/or the revision of the General Pharmaceutical Legislation were discussed (up to 26 April 2023).
(2) Any written correspondence from external stakeholders which directly concerns the Pharmaceutical Strategy or the revision of the General Pharmaceutical Legislation (up to 26 April 2023) and, if applicable, the response from VP Schinas and/or members of his cabinet. Please include any documents attached to such correspondence.

If you have any questions or require clarification of the scope of the request, please do not hesitate to contact me. I would be glad to discuss the request and refine its parameters if appropriate. In case it is helpful to have some context, we are seeking to better understand the Commission’s stakeholder engagement processes as part of a research project.

Yours sincerely,
Dr Kathrin Lauber

University of Edinburgh, School of Social and Political Science
Chrystal Macmillan Building
15a George Square
EH8 9LD, Edinburgh

Sg-Acc-Doc@ec.europa.eu, Secrétariat général de la Commission européenne

Your message has been received by the Transparency Unit of the
Secretariat-General of the European Commission.
Requests for public access to documents are treated on the basis of
[1]Regulation (EC) No 1049/2001 of 30 May 2001 regarding public access to
European Parliament, Council and Commission documents.
The Secretariat-General will reply to your request within 15 working days
upon registration of your request and will duly inform you of the
registration of the request (or of any additional information to be
provided in view of its registration and/or treatment).
 
 
L’unité «Transparence» du secrétariat général de la Commission européenne
a bien reçu votre message.
Les demandes d’accès du public aux documents sont traitées sur la base du
[2]règlement (CE) n° 1049/2001 du 30 mai 2001 relatif à l’accès du public
aux documents du Parlement européen, du Conseil et de la Commission.
Le secrétariat général répondra à votre demande dans un délai de 15 jours
ouvrables à compter de la date d’enregistrement de votre demande, et vous
informera de cet enregistrement (ou vous indiquera toute information
supplémentaire à fournir en vue de l'enregistrement et/ou du traitement de
votre demande).
 
 
Ihre Nachricht ist beim Referat „Transparenz“ des Generalsekretariats der
Europäischen Kommission eingegangen.
Anträge auf Zugang zu Dokumenten werden auf der Grundlage der
[3]Verordnung (EG) Nr. 1049/2001 vom 30. Mai 2001 über den Zugang der
Öffentlichkeit zu Dokumenten des Europäischen Parlaments, des Rates und
der Kommission behandelt.
Das Generalsekretariat beantwortet Ihre Anfrage innerhalb von
15 Arbeitstagen nach deren Registrierung und wird Sie über die
Registrierung Ihres Antrags (oder die Notwendigkeit weiterer Informationen
im Hinblick auf dessen Registrierung und/oder Bearbeitung) unterrichten.
 
 

References

Visible links
1. https://eur-lex.europa.eu/legal-content/...
2. https://eur-lex.europa.eu/legal-content/...
3. https://eur-lex.europa.eu/legal-content/...

sg-acc-doc@ec.europa.eu,

Dear Sir or Madam,

We hereby acknowledge the receipt of your request for access to documents
sent on 23/06/2023 and registered on 23/06/2023 under the case number
2023/3576.

We will handle your request within 15 working days as of the date of
registration. The time-limit expires on 14/07/2023. We will let you know
if we need to extend this time limit for additional 15 working days.

To find more information on how we process your personal data, please see
[1]the privacy statement.

Yours faithfully,

Secretariat-General - Access to Documents
European Commission

References

Visible links
1. https://ec.europa.eu/info/principles-and...

sg-acc-doc@ec.europa.eu,

1 Attachment

Hello,

Please find attached a message concerning your request for access to
Commission documents registered under the above case number 2023/3576.

Kind regards,

Dear Secretariat-General Access to Documents team,

Many thanks for your message.

As my request concerns the revision of the general pharmaceutical legislation, I propose to start in March 2021 when the inception impact assessment was published. Based on the response of the lead DG of this initiative to a similar request we submitted, I anticipate this should be feasible in terms of scope, but please don't hesitate to let me know if any issues arise.

Yours faithfully,
Dr Kathrin Lauber

SG-UNITE-E-4@ec.europa.eu, Secrétariat général de la Commission européenne

Hello,

 

We are writing concerning your request for access to Commission documents
registered on 23/06/2023 under case number 2023/3576.

 

We are currently working on your request. However, we have not yet been
able to gather all the elements necessary to carry out a full analysis of
your request. We will not be able to send you the reply within the
prescribed time limit expiring on 09/08/2023, as there are documents
originating from from third parties, which have been consulted.

 

Therefore, in line with Article 7(3) of [1]Regulation (EC) No 1049/2001,
we need to extend this time limit by 15 additional working days. The new
time limit expires on 31/08/2023.

 

We apologise for any inconvenience this may cause.

 

Kind regards,

 

 

From: [SG request email]
<[email address]>
Sent: Tuesday, July 11, 2023 9:45 AM
To: [FOI #13182 email]
Cc: SG UNITE E-4 <[email address]>
Subject: Your application for access to documents - 2023/3576

 

Hello,

Please find attached a message concerning your request for access to
Commission documents registered under the above case number 2023/3576.

Kind regards,

References

Visible links
1. https://eur-lex.europa.eu/legal-content/...

Hello,

Please can you provide me with an update on this request (EASE 2023/3576)? It's several months overdue.

Yours sincerely,
Kathrin Lauber

sg-acc-doc@ec.europa.eu,

20 Attachments

  • Attachment

    Document 10 Peter Guenter CEO of Merck Healthcare 30 November 2021.pdf

    400K Download View as HTML

  • Attachment

    Document 11 Meeting VP Schinas with Medicines for Europe 08 October 2021.pdf

    419K Download View as HTML

  • Attachment

    Document 12 Meeting VP Schinas with Boehringer Ingelheim 08 October 2021.pdf

    408K Download View as HTML

  • Attachment

    Document 13 Meeting VP Schinas European Federation of Pharmaceutical Industries and Associations EFPIA 21.6.2021.pdf

    406K Download View as HTML

  • Attachment

    Document 14.1 Letter medicine shortages.pdf

    410K Download View as HTML

  • Attachment

    Document 14 Letter from MEPs on medicine shortages.pdf

    424K Download View as HTML

  • Attachment

    Document 15 Re Letter from MEPs on medicine shortages.pdf

    558K Download View as HTML

  • Attachment

    Document 16.1 15.07.2022 EFPIA Presidency letter to Vice President Schinas and Commissioner Kyriakides.pdf

    437K Download View as HTML

  • Attachment

    Document 16.2 Annex to letter of 15 July 2022.pdf

    718K Download View as HTML

  • Attachment

    Document 16 Thank you and follow up to the meeting of 29 June 2022.pdf

    380K Download View as HTML

  • Attachment

    Document 1 Minutes Meeting with GIRP.pdf

    492K Download View as HTML

  • Attachment

    Document 2 Minutes Meeting with EFPIA 21.03.2023.pdf

    430K Download View as HTML

  • Attachment

    Document 3 Minutes Meeting with Medicines for Europe 17.03.2023.pdf

    433K Download View as HTML

  • Attachment

    Document 4 Minutes Meeting with European Patients Forum and the Public Health Alliance 06.03.2023.pdf

    433K Download View as HTML

  • Attachment

    Document 5 Flash meeting HoC with Novartis International 21.03.2023.pdf

    412K Download View as HTML

  • Attachment

    Document 6 Meeting Head of Cabinet V P Schinas with Medicines for Europe 09 November 2022.pdf

    276K Download View as HTML

  • Attachment

    Document 7 Meeting between Vice President Schinas and Commissioner Stella Kyriakides and EFPIA on the revision of the general pharma legislation 29 June 2022.pdf

    959K Download View as HTML

  • Attachment

    Document 8 Meeting VP Schinas with Medicines for Europe.pdf

    401K Download View as HTML

  • Attachment

    Document 9 Meeting VP Schinas with the Hellenic Association of Pharmaceutical Companies 08 April 2022.pdf

    406K Download View as HTML

  • Attachment

    Partial reply EASE 2023.3576.pdf

    844K Download View as HTML

Dear Mr Schmidt,

Please find attached a message concerning your request for access to
Commission documents registered under the above case number 2023/3576.

Kind regards,

Dear Secretariat General of the European Commission,

Many thanks for your response to my access to documents request number 2023/3576. I confirm that this has been received.

With kind regards,
Kathrin Lauber